We are international
Donate
• treatment options TEXT SIZE   
novel therapies    back

Understanding Kyprolis® (carfilzomib) for Injection

This booklet discusses Kyprolis® (carfilzomib), the results of clinical trials with Kyprolis, how and when Kyprolis is administered, and the possible side effects of Kyprolis and how to manage them. Kyprolis is in a new class of drugs called proteasome inhibitors. It works by blocking the activity of enzyme complexes called proteasomes. 

 

03.11.14
You can view the entire document as a PDF by clicking on the icon below, or by requesting a free hard copy from the Foundation.

This booklet discusses Kyprolis, the results of clinical trials with Kyprolis, how and when it is administered, its possible side effects, and how to manage them.

For updated dosing recommendations, please click here to view the 2014 edition of the Kyprolis Tip Card.


 related articles